Virtual Library
Start Your Search
Tom Stinchcombe
Moderator of
-
+
Immune Checkpoint Inhibitors as Single Agents (ID 3)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 8
- Moderators:Bruce Robinson, Tom Stinchcombe
- Coordinates: 7/11/2019, 09:00 - 09:45, Westin New York at Times Square
-
+
Atezolizumab (ID 20)
09:00 - 09:45 | Author(s): Aaron Mansfield
- Abstract
Abstract not provided
-
+
Avelumab (ID 22)
09:00 - 09:45 | Author(s): Melina Marmarelis
- Abstract
Abstract not provided
-
+
Durvalumab (ID 21)
09:00 - 09:45 | Author(s): Anna Nowak
- Abstract
Abstract not provided
-
+
Nivolumab (ID 18)
09:00 - 09:45 | Author(s): Matthew Gubens
- Abstract
Abstract not provided
-
+
Nivolumab-Japan MERIT Trial (ID 19)
09:00 - 09:45 | Author(s): Yasushi Goto
- Abstract
Abstract not provided
-
+
Pembrolizumab (ID 17)
09:00 - 09:45 | Author(s): Corey Langer
- Abstract
Abstract not provided
-
+
Science of Checkpoint Inhibitors (ID 16)
09:00 - 09:45 | Author(s): Paul Baas
- Abstract
Abstract not provided
-
+
Tremelimumab (ID 23)
09:00 - 09:45 | Author(s): Luana Calabr
- Abstract
Abstract not provided
Author of
-
+
FGFR/PDGFR/Angiogenesis Session (ID 2)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Giorgio Scagliotti, Mary Hesdorffer, NP
- Coordinates: 7/11/2019, 07:45 - 08:45, Westin New York at Times Square
-
+
Imatinib Mesylate (ID 7)
07:45 - 08:45 | Author(s): Tom Stinchcombe
- Abstract
Abstract not provided
-
+
Immune Checkpoint Inhibitors + Chemo or Other Immune Combination Co-Stimulatory and Co-Inhibitor Molecules (ID 14)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Dean Fennell, Anne Tsao
- Coordinates: 7/12/2019, 10:15 - 11:40, Westin New York at Times Square
-
+
LAG525 + Spartalizumab (ID 107)
10:15 - 11:40 | Author(s): Tom Stinchcombe
- Abstract
Abstract not provided